Peptide

Details for Australian Patent Application No. 2006245512 (hide)

Owner Oxford BioMedica (UK) Limited

Inventors Harrop, Richard; Shingler, William; Kingsman, Susan

Agent Davies Collison Cave

Pub. Number AU-B-2006245512

PCT Pub. Number WO2006/120473

Priority 0516303.5 08.08.05 GB; 0509835.5 13.05.05 GB

Filing date 12 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 22 December 2011

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/120473 Priority application(s): WO2006/120473

22 December 2011 Application Accepted

  Published as AU-B-2006245512

19 April 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245517-Quinoline derivatives as neurokinin receptor antagonists

2006245508-Therapeutic sclerosing foam made preferably xenon